The Largest Personal Injury Firm in Texas. Serving Clients Nationwide.
Austin 512-520-0221 Corpus Christi 361-254-7873 San Antonio 210-874-2615 Nationwide Toll Free 866-517-5659
Contact us 24/7 Contact us 24/7

Our attorneys and staff continue to work through COVID-19 and remain available 24/7, ready to fight for you. Our video conferencing, case management, and telecommunications systems allow us to stay in constant contact with our clients and pursue their claims without interruption – all without our clients leaving the comfort of their homes. You focus on staying healthy and safe, we’re here to handle the rest.

Thomas J. Henry Investigating Heart Failure in Hepatitis C Trials

View all

San Antonio, TX (PRWEB) September 05, 2012

Patients taking an experimental Hepatitis C drug have suffered heart failure and valve damage, prompting Bristol-Myers Squibb to unexpectedly halt all work on the drug.

The Thomas J. Henry Law Firm is currently screening cases from all over the country related to the Daclatasvir/ BMS-986094 clinical trials.

People have suffered life-changing, debilitating injuries as a result of these clinical trials.
Thomas J. Henry, Attorney

“We have already interviewed a number of injury victims from the Hepatitis C trials,” Thomas J. Henry said. “More calls are coming in and there are lawsuits already on file. People have suffered life-changing, debilitating injuries as a result of these clinical trials.”

The clinical trials were halted following the report of one death. Bristol-Myers discontinued development of BMS-986094 after reports of eight hospitalizations, the Wall Street Journal recently reported. In addition, a similar drug – IDX-184 by Idenix Pharmaceuticals – has also been placed on partial clinical hold.

Originally hailed as a possible breakthrough in Hepatitis C treatment, BMS-986094 may actually be toxic to the heart and kidneys. Hundreds of people took the drug for clinical trials before this potentially dangerous flaw was discovered. Injuries reported in trial patients include:

  • Heart valve damage
  • Heart attacks and heart failure
  • Kidney damage
  • Abnormal heart rhythms
  • Fatal heart damage

Bristol is monitoring more than 100 patients who took part in the halted trial and is notifying 150 patients who were part of earlier trials, according to the Wall Street Journal. The Hepatitis C trials took place in various medical facilities across the country, including:

If you or a loved one participated in this trial and suffered damage, you are encouraged to contact an attorney immediately. Thomas J. Henry are available 24/7, night and day, at 888-956-8000 or




Contact Information

The Law Offices of Thomas J. Henry
(361) 985-0600

Do you really want to end conversation?
chat-icon Live chat
avatar Waiting